Expected earnings - Enzon Pharmaceuticals Inc
Source: US Earnings Reports
Enzon Pharmaceuticals Inc (ENZN) is expected to report for Q2 2025
Enzon Pharmaceuticals Inc
NASDAQ: ENZN
ENZN Trading
-19.8% G/L:
$0.0401 Last:
2,000 Volume:
$0.0401 Open:
ENZN Latest News
February 27, 2026 08:45:00 am
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
ENZN Stock Data
$47,868
742,146
0.27%
7
259381%
Biotechnology & Life Sciences
Healthcare
US
Cranford
